Key result
Flame retardant TDCPP links to atherosclerosis via ~125 shared genes and chemokine receptor binding.
Why the study?
Epidemiological studies have associated Tris(1,3-dichloro-2-propyl) phosphate (TDCPP) exposure with cardiovascular disease risk, but the mechanisms by which TDCPP may contribute to atherosclerosis formation remained unclear.
Answers are grounded in this paper and cite their sources.
Integrative in silico analyses suggest TDCPP exposure may link to atherosclerosis via chemokine-mediated immune-cell trafficking and inflammatory signaling targeting CCR1, CCR2, CCR7, CXCR3, and JAK3.
Tris(1,3-dichloro-2-propyl) phosphate (TDCPP) is an organophosphate flame retardant widely detected in the environment, raising concerns regarding its long-term health effects. Epidemiological studies have associated TDCPP exposure with the risk of cardiovascular diseases. However, the mechanisms by which TDCPP exposure may contribute to cardiovascular diseases, particularly through atherosclerosis formation, remain unclear. Our study aimed to investigate the potential biomolecular mechanisms linking TDCPP to atherosclerosis through in silico analyses, including network toxicology, protein-protein interaction (PPI) network analysis, transcriptomic profiling, and molecular docking. Genes related to TDCPP and atherosclerosis were retrieved from open-access databases. We identified 125 intersecting genes between TDCPP- and atherosclerosis-related gene sets, which were associated with inflammatory signaling pathways, particularly cytokine- and chemokine-related processes and leukocyte migration. PPI network analysis identified CCR1, CCR2, CCR7, CXCR3, and JAK3 as potential core gene targets. Further analysis of potential cellular targets by mapping to a human atherosclerotic plaque single-cell transcriptomic atlas indicated that these five genes were mainly expressed in immune-cell populations, particularly myeloid and lymphoid cells. Transcriptomic analysis showed higher expression of all five genes in atherosclerotic tissues than in controls across arterial territories, while CCR1, CCR2, and JAK3 consistently showed higher expression in advanced atherosclerotic lesions. Molecular docking revealed that CCR7 and CCR2 had favorable docking scores with TDCPP (-5.801 and -5.627 kcal/mol, respectively). Overall, our findings indicate potential molecular mechanisms linking TDCPP to atherosclerosis through chemokine-mediated immune-cell trafficking and inflammatory signaling. Further studies are necessary to validate the relevance of these candidate targets and pathways.
No takes yet. Share an insight, caveat, or question.
Sastrawan et al. (2026) studied Atherosclerosis. Tris(1,3-dichloro-2-propyl) phosphate (TDCPP) vs. Control / non-atherosclerotic or early lesion arterial tissues was evaluated on Intersecting molecular target genes, differential gene expression in atherosclerotic tissues, and molecular docking scores with TDCPP (p=<0.05). TDCPP shared 125 genes with atherosclerosis (5 core targets: CCR1, CCR2, CCR7, CXCR3, JAK3) and showed favorable docking with CCR7 and CCR2.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: